Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 7Breast 2Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 5Urinary Bladder Neoplasms 3Uterine Cervical Neoplasms 1Sarcoma 1Salivary Gland Adenoma, Pleomorphic 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Hyperthermia 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 31Nivolumab 12Cyclophosphamide 10fludarabine 9aldesleukin 8atezolizumab 7durvalumab 6Magnetic Resonance Spectroscopy 6Trastuzumab 5Specimen Handling 5Paclitaxel 5Ipilimumab 5Docetaxel 5Biopsy 5fludarabine phosphate 4Radiotherapy 4Interleukin-2 4Gene Expression Profiling 4Carboplatin 4tisotumab vedotin 3cemiplimab 3aflibercept 3Polymerase Chain Reaction 3Immunoglobulin G 3Early Intervention, Educational 3Cisplatin 3Bevacizumab 3tremelimumab 2tislelizumab 2osimertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Diathermy × Genitourinary × Clear all
NCT00911079 2021-07-07

Pilot Study of a Catheter-based Ultrasound Hyperthermia System

University of California, San Francisco

Phase NA Terminated
13 enrolled
GenitourinaryGynecologicHead & Neck

Salivary Gland Adenoma, Pleomorphic, Uterine Cervical Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡